Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes

Endocrinology

Volumn 148, Issue 2, 2007, Pages 594-608

  Gonzalez Rodriguez, Agueda ^a,b   Clampit, Jill E ^c   Escribano, Oscar ^b   Benito, Manuel ^b   Rondinone, Cristina M ^c,e   Valverde, Angela M ^a,b,d  

^a CSIC   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c ABBOTT LABORATORIES   (United States)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^e HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE 1B;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; GLUCONEOGENESIS; INSULIN SENSITIVITY; LIVER CELL; MALE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGING; ANIMALS; ANIMALS, NEWBORN; CELL LINE, TRANSFORMED; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TRANSFER TECHNIQUES; GLUCONEOGENESIS; HEPATOCYTES; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, INSULIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TYROSINE; UP-REGULATION;

EID: 33846548680     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0644     Document Type: Article

References (52)

1. Klover PJ, Mooney, RA 2004 Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol 36:753-758
2. Radziuk J, Pye S 2001 Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 17:250-272
3. Saltiel AR, Kahn CR 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
4. White MF 2002 IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283:E413-E422
5. Backer JM, Myers Jr MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF 1992 Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479
6. Michael MD, Kulkarni RN, Postic C, Previs SF, Schulman GI, Magnuson MA, Kahn CR 2000 Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97
7. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904
8. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T 2000 Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49:1880-1889
9. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flintcell CL, White MF 1999 IRS-2 coordinates IGF-I receptor-mediated development and peripheral insulin signalling. Nat Genet 23:32-40
10. Dong X, Park S, Lin X, Copps K, Yi X, White M 2006 Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest 116:101-114
11. Valverde AM, Burks D, Fabregat I, Fisher T, Carretero J, White MF, Benito M 2003 Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52:2239-2248
12. Valverde AM, Fabregat I, Burks DJ, White MF, Benito M 2004 IRS-2 mediates the anti-apoptotic effect of insulin in neonatal hepatocytes. Hepatology 40: 1285-1294
13. Mora A, Lipina C, Tronche F, Sutherland C, Alessi DR 2005 Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure. Biochem J 385:639-648
14. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw 3rd EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ 2001 Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728-1731
15. Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M 2002 Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest 110:1483-1491
16. Tonks NK, Neel BG 2001 Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 13:182-195
17. Goldstein BJ, Ahmad F, Ding W, Li PM, Zhang WR 1998 Regulation of the insulin signaling pathway by cellular protein-tyrosine phosphatases. Mol Cell Biochem 182:91-99
18. Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D 2000 Molecular basis for recognition and dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6:1401-1412
19. Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM 1996 Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45:1379-1385
20. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M 2000 Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem 275:4283-4289
21. Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A 2001 Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells. J Biol Chem 276:10207-10211
22. Clampit JE, Meuth JL, Smith HT, Reilly RM, Jirousek MR, Trevillyan JM, Rondinone CM 2003 Reduction of protein-tyrosine phosphatase-1B increases insulin signaling in FAO hepatoma cells. Biochem Biophys Res Commun 300:261-267
23. Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA, Trevillyan JM, Ulrich RG, Jirousek MR, Rondinone CM 2003 Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52:21-28
24. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP 1999 Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-1548
25. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB 2000 Increased energy expenditure, decreased adiposity and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479-5489
26. Haj FG, Zabolotny JM, Kim YB, Kahn BB, Neel BJ 2005 Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/- mice. J Biol Chm 280:15038-15046
27. Fabregat I, Lorenzo M, Benito M 1989 Precocious induction of malic enzyme by nutritional and hormonal factors in rat foetal hepatocyte primary cultures. Biochem Biophys Commun 161:1028-1034
28. Benveniste R, Danoff TM, Ilekis J, Craig HR 1988 Epidermal growth factor receptor numbers in male and female mouse primary hepatocyte cultures. Cell Biochem Funct 4:231-235
29. Rondinone CM, Clampit J, Gum, RJ, Zinker BA, Jirousek MR, Trevillyan JM 2004 Reduction of PTP1B induces differential expression of PI3-kinase (p85α) isoforms. Biochem Biophys Res Commun 323:652-659
30. Valverde AM, Lorenzo M, Navarro P, Benito M 1997 Phosphatidylinositol 3-kinase is a requirement for insulin-like growth factor-I-induced differentiation, but not for mitogenesis, in fetal brown adipocytes. Mol Endocrinol 11:595-607
31. Guillen C, Navarro P, Robledo M, Valverde AM, Benito M 2006 Differential mitogenic signaling in insulin receptor-deficient fetal pancreatic β-cells. Endocrinology 147:1959-1968
32. Ivaska J, Nissinen L, Immonen N, Eriksson JE, Kahari VM, Heino J 2002 Integrin α2β1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3β. Mol Cell Biol 22:1352-1359
33. Ugi, S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, Kashiwagi A, Olefsky JM 2004 Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 24:8778-8789
34. Shimizu S, Ugi S, Maegawa H, Maegawa H, Egawa K, Nishio Y, Yoshizaki T, Shi K, Nagai Y, Morino K, Nemoto K, Nakamura T, Bryer-Ash M, Kashiwagi A 2003 Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem 278:43095-43101
35. Qiu W, Avramoglu RK, Dube N, Chong TM, Naples M, Au C, Sidiropoulos KG, Lewis GF, Cohn JS, Tremblay ML, Adeli K 2004 Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies. Diabetes 53:3057-3066
36. Liu G, Trevillyan JM 2000 Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes. Curr Opin Investig Drugs 3:1608-1616
37. Wang J, Cheung AT, Kolls JK, Starks WW, Martinez-Hernandez A, Dietzen D, Bryer-Ash M 2001 Effects of adenovirus-mediated liver-selective overexpression of protein tyrosine phosphatase-1b on insulin sensitivity in vivo. Diabetes Obes Metab 3:367-380
38. Kushner JA, Haj FG, Klaman LD, Dow MA, Kahn BB, Neel BJ, White MF 2004 Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes 53:61-66
39. Garlic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T 2005 Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol 25:819-829
40. Issad T, Boute N, Boubekeur S, Lacasa D 2005 Interaction of PTPB with the insulin receptor precursor during its biosynthesis in the endoplasmic reticulum. Biochimie (Paris) 87:111-116
41. Frame S, Cohen P, Biondi RM 2001 A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7:321-1327
42. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Bleni J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
43. Biggs WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC 1999 Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the wingle helix transcription factor FKHRL1. Proc Natl Acad Sci USA 96:7421-7426
44. Del Peso L, Gonzalez VM, Hernandez R, Barr F, Nuñez G 1999 Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 18:7328-7333
45. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, Granner DK 2000 Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. J Biol Chem 275:30169-30175
46. Schmoll D, Walker KS, Alessi D, Grempler R, Burchell A, Guo S, Walther R, Unterman TG 2000 Regulation of glucose-6-phosphatase gene expression by protein kinase B α and the forkhead transcription factor FKHR. J Biol Chem 275:36324-36333
47. Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, Heidenreich KA, Sajan MP, Farese RV, Stolz DB, Tso P, Koo SH, Montminy M, Unterman TG 2006 Foxo1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281:10105-10117
48. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM 2001 Control of hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:131-138
49. Park EA, Gurney AL, Nizielski SE, Hakimi P, Cao Z, Moorman A, Hanson RW 1999 Relative roles of CCAAT/enhancer-binding protein β and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J Biol Chem 268:613-619
50. Kawazoe Y, Naka T, Fujimoto M, Kohzaki H, Morita Y, Narazaki M, Okumura K, Saitoh H, Nakagawa R, Uchiyama Y, Akira S, Kishimoto T 2001 Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J Exp Med 193:263-269
51. Araki E, Lipes MA, Patti ME, Brüning JC, Haag III BL, Johnson RS, Kahn CR 1994 Alternative pathway of insulin signalling in mice made with targeted disruption of the IRS-1 gene. Nature 372:186-190
52. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, Goodyear LJ, Iannacone M, Accili D, Cantley LC, Kahn CR 2002 Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest 109:141-149